Soluble PD-L1 in the circulation is thought to be produced as a result of alternative mRNA splicing or proteolytic cleavage of PD-L1 at the cell surface in tumor cells or mature dendric cells (18–20). This evidence concerns the gene CD274 and neoplasm.